Gilead Says HIV Pill May Be Available in ’06
- Share via
Gilead Sciences Inc. Chief Executive John Martin said a triple combination HIV pill that the Foster City, Calif., company would sell with Bristol-Myers Squibb Co. and Merck & Co. might reach the market this year.
Gilead will file for Food and Drug Administration approval of the drug, the first to put three HIV medicines together in a once-a-day pill, in the second quarter, Martin said.
Researchers showed that a single pill combining Gilead’s Viread and Emtriva medicines and Bristol-Myers’ Sustiva was equivalent to taking the three drugs separately, Gilead said.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
